Kestra Advisory Services’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $319K | Buy |
5,763
+582
| +11% | +$32.2K | ﹤0.01% | 2290 |
|
|
2025
Q1 | $251K | Sell |
5,181
-466
| -8% | -$22.5K | ﹤0.01% | 2308 |
|
|
2024
Q4 | $218K | Buy |
5,647
+464
| +9% | +$17.9K | ﹤0.01% | 2422 |
|
|
2024
Q3 | $233K | Buy |
+5,183
| New | +$233K | ﹤0.01% | 2255 |
|
|
2022
Q1 | – | Sell |
-7,833
| Closed | -$268K | – | 2099 |
|
|
2021
Q4 | $268K | Buy |
+7,833
| New | +$268K | ﹤0.01% | 1672 |
|
|
2021
Q3 | – | Sell |
-13,939
| Closed | -$626K | – | 2164 |
|
|
2021
Q2 | $626K | Buy |
13,939
+310
| +2% | +$13.9K | 0.01% | 1163 |
|
|
2021
Q1 | $353K | Buy |
+13,629
| New | +$353K | ﹤0.01% | 1365 |
|